• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Moderna

vaccines
Posted inCOVID-19, Infections, New Drugs, Regulatory

Pfizer and Moderna Release Booster Vaccines to Protect Against Omicron

September 1, 2022September 20, 2022

Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.

moderna-vaccine
Posted inCOVID-19, Infections, Pharma & Biotech

Moderna Declared War on Pfizer

August 29, 2022September 8, 2022

Billions of dollars made from vaccines are at stake.

vaccine
Posted inCOVID-19, Infections, New Drugs, Regulatory

First Omicron Vaccine Appears

August 15, 2022September 8, 2022

Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.

coronavirus
Posted inCOVID-19, Infections, Research

Three Billion Omicron Cases

December 25, 2021September 8, 2022

Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.

coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

December 17, 2021September 8, 2022

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.

Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis

December 9, 2021September 8, 2022

The combination drug will help almost all cystic fibrosis patients.

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

April 3, 2021September 8, 2022

A deadly disease and modern pharmacological attempts to treat it.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News